Amar Rewari, MD
Radiation Oncology · Germantown, MDNPI 1336458942
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $377 and has fallen 84.1% since, to $60 in 2025.
Across 16 payments — averaging $55.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$122
- Novocure Inc.$121
- GT Medical Technologies, Inc$114
- Focal Therapeutics, Inc.$102
- Reflexion Medical, Inc.$96
- AbbVie$85
- plus $254 from 7 others
Across 3 payments — averaging $17,078 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novocure Inc.$51K
What the payments were for
- Food & beverage$893100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 1 | $122 |
| Novocure Inc. | 1 | $121 |
| GT Medical Technologies, Inc | 1 | $114 |
| Focal Therapeutics, Inc. | 2 | $102 |
| Reflexion Medical, Inc. | 1 | $96 |
| AbbVie | 1 | $85 |
| Johnson & Johnson | 3 | $84 |
| Bioprotect Medical, Inc. | 1 | $42 |
| Palette Life Sciences, Inc. | 1 | $37 |
| Pfizer | 1 | $24 |
| Boston Scientific | 1 | $24 |
| G1 Therapeutics, Inc. | 1 | $22 |
| Fortovia Therapeutics, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Varian Ethos Treatment Planning$122
- Optune$121
- GammaTile$114
How this compares
$893 in reported general payments places this provider in the 55th percentile of 108 radiation oncology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 32 | $325 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Germantown
- Sahaja AcharyaBaltimore$200K
- Arpit ChhabraBaltimore$97K
- Robert BrooklandTowson$34K
- Lawrence KleinbergBaltimore$34K
- Danny SongBaltimore$32K
- Jason MolitorisBaltimore$26K
- Kristin RedmondBaltimore$17K
- John MansuetiBerlin$11K
- Avani RaoBaltimore$10K
- Lawrence ShombertCumberland$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.